FDA Mines Small Field Of Industry Candidates To Fill Executive Vacancies
This article was originally published in The Tan Sheet
Criteria for FDA’s leadership posts are extensive and the hiring process is long, but Richard Moscicki still believes industry and academics should consider applying. As more long-time officials retire, he says it is critical to fill open positions to allow for a “smooth transition over an extended period of time.”
You may also be interested in...
New position in CDER’s Office of New Drugs is expected to deal with internal workings of the office.
Howard Sklamberg, currently director of the CDER Office of Compliance, will take over the Office of Global Regulatory Operations and Policy after a year as CDER compliance office director.
Office of Medical Policy’s leadership gets reshuffled following retirement of the long-time CDER denizen Rachel Sherman.